DEVELOPMENT OF PORTABLE DIAGNOSTIC TOOLS FOR RAPID DETECTION OF METAPNEUMOVIRUS IN HUMANS

Widang  Muttaqin; Annisa  Desianty; Khansa  Farah Fitriani; Aurellia  Fira Artanti; Daniswara  Rafi Pandora

doi:10.33330/jurteksi.v12i2.4410

Widang Muttaqin Universitas Telkom
Annisa Desianty Universitas Telkom
Khansa Farah Fitriani Universitas Telkom
Aurellia Fira Artanti Universitas Telkom
Daniswara Rafi Pandora Universitas Telkom

DOI: https://doi.org/10.33330/jurteksi.v12i2.4410

Keywords: human metapneumovirus (hmpv), portable diagnostic, rapid detection, CRISPR-Cas, air quality sensors, internet of things, public health

Abstract

Abstract: Human metapneumovirus (HMPV) poses a global health threat, but its detection remains challenging due to limited environmental monitoring. This study aims to develop a portable diagnostic tool for rapid HMPV detection by integrating cutting-edge biotechnology (CRISPR-Cas system and immunoassay) with air quality sensors on an Internet of Things (IoT)-based microfluidic platform controlled by an ESP32 microcontroller. The system is supported by a companion application and data analysis using Vertex AI, and is capable of providing results in less than fifteen minutes. The development results demonstrate the potential for improving detection accuracy and reliability, particularly with further development of virus-specific biosensors, sensor optimization, and algorithms. This technology is effective as a complementary tool for early screening and environment-based risk management in areas with limited laboratory facilities, although it does not completely replace molecular diagnostic methods such as PCR. A rapid diagnostic approach based on environmental sensors, IoT, and artificial intelligence is a promising strategy to improve early HMPV detection, accelerate public health responses, and strengthen respiratory infection prevention through integrated environmental monitoring and education functions.

Keywords: air quality; CRISPR-Cas; Human Metapneumovirus (HMPV); Internet of Things, portable diagnostic; public health; rapid detection; sensors.

Abstrak: Human metapneumovirus (HMPV) merupakan ancaman bagi kesehatan global, namun pendeteksiannya masih sulit akibat keterbatasan pemantauan lingkungan. Studi ini bertujuan mengembangkan alat diagnostik portabel untuk deteksi cepat HMPV melalui integrasi bioteknologi mutakhir (sistem CRISPR-Cas dan immunoassay) dengan sensor kualitas udara pada platform mikrofluida berbasis Internet of Things (IoT) yang dikendalikan mikrokontroler ESP32. Sistem ini didukung aplikasi pendamping dan analisis data menggunakan Vertex AI, serta mampu memberikan hasil dalam waktu kurang dari lima belas menit. Hasil pengembangan menunjukkan potensi peningkatan akurasi dan keandalan deteksi, terutama dengan pengembangan lanjutan berupa biosensor spesifik virus, optimalisasi sensor, dan algoritma. Teknologi ini efektif sebagai alat pelengkap untuk skrining awal dan manajemen risiko berbasis lingkungan di wilayah dengan keterbatasan fasilitas laboratorium, meskipun tidak sepenuhnya menggantikan metode diagnostik molekuler seperti PCR. Pendekatan diagnostik cepat berbasis sensor lingkungan, IoT, dan kecerdasan buatan menjadi strategi menjanjikan untuk meningkatkan deteksi dini HMPV, mempercepat respons kesehatan masyarakat, serta memperkuat pencegahan infeksi saluran pernapasan melalui fungsi pemantauan dan edukasi lingkungan yang terintegrasi.

Kata kunci: CRISPR-Cas; diagnostik portabel; deteksi cepat; Human Metapneumovirus (HMPV); kesehatan masyarakat; IoT (Internet of Things); sensor kualitas udara.

References

Y. Feng, T. He, B. Zhang, H. Yuan, and Y. Zhou, “Epidemiology and diagnosis technologies of human metapneumovirus in China: a mini review,” Virol. J., vol. 21, no. 1, p. 59, 2024, doi: 10.1186/s12985-024-02327-9.

“Human Metapneumovirus (hMPV) | American Lung Association.” Accessed: Jan. 06, 2026. [Online]. Available: https://www.lung.org/lung-health-diseases/lung-disease-lookup/human-metapneumovirus-hmpv

W. Qian, J. Huang, T. Wang, X. He, G. Xu, and Y. Li, “Visual detection of human metapneumovirus using CRISPR‐Cas12a diagnostics,” Virus Res., vol. 305, p. 198568, Nov. 2021, doi: 10.1016/J.VIRUSRES.2021.198568.

“Human Metapneumovirus (HMPV): Symptoms & Treatment.” Accessed: Mar. 11, 2026. [Online]. Available: https://my.clevelandclinic.org/health/diseases/22443-human-metapneumovirus-hmpv

C. J. Russell, R. R. Penkert, S. Kim, and J. L. Hurwitz, “Human metapneumovirus: A largely unrecognized threat to human health,” Pathogens, vol. 9, no. 2, pp. 1–8, 2020, doi: 10.3390/pathogens9020109.

Z. Zhang et al., “Advanced Point-of-Care Testing Technologies for Human Acute Respiratory Virus Detection,” Adv. Mater., vol. 34, no. 1, pp. 1–39, 2022, doi: 10.1002/adma.202103646.

J. Lukose, S. Chidangil, and S. D. George, “Optical technologies for the detection of viruses like COVID-19: Progress and prospects,” Biosens. Bioelectron., vol. 178, p. 113004, Apr. 2021, doi: 10.1016/j.bios.2021.113004.

K. Hu et al., “CRISPR-Based Biosensors for Medical Diagnosis: Readout from Detector-Dependence Detection Toward Naked Eye Detection,” Biosensors, vol. 14, no. 8, 2024, doi: 10.3390/bios14080367.

“Vertex AI Platform | Google Cloud.” Accessed: Jan. 06, 2026. [Online]. Available: https://cloud.google.com/vertex-ai

M. I. Tushar, S. Islam, N. L. Nishuty, S. Islam, M. S. Islam, and M. R. Islam, “The pathogenicity and potential risk evaluation of human metapneumovirus (hMPV) for global public health,” Discov. public Heal., vol. 22, no. 1, 2025, doi: 10.1186/s12982-025-00914-x.